Generic MS Drug Development Was Protected, Sandoz Says
Sandoz Inc. asked a New York federal judge Wednesday to toss Teva Pharmaceuticals Industries Ltd.'s patent infringement suit, saying its use of a patented process as it developed a generic form...To view the full article, register now.
Already a subscriber? Click here to view full article